Stock Events

Stock Events

SkinBioTherapeutics 

GBX0.1
10
+GBX0+0% Friday 07:00

Statistics

Day High
0.1
Day Low
0.1
52W High
26.1
52W Low
0.1
Volume
-
Avg. Volume
-
Mkt Cap
252,309.51
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31MarExpected
Q4 2022
Q3 2023
Q4 2023
Q3 2024
Q4 2024
Q3 2025
Q4 2025
-0.76
-0.65
-0.55
-0.44
Expected EPS
N/A
Actual EPS
N/A

Financials

-15.01%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
927.6MRevenue
-139.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SBTX.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evotec
EVO
Mkt Cap1.1B
Evotec SE, operates in the biotechnology field focusing on drug discovery and development, directly competing with SkinBioTherapeutics' efforts in developing therapies.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics, specializes in gene editing, a technology that could be applied to skin conditions, making it a competitor in innovative therapeutic approaches.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.51B
Alnylam Pharmaceuticals, focuses on RNAi therapeutics, competing in the broader biotech space for dermatological and other conditions.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals, develops monoclonal antibodies for dermatological conditions, directly competing in the skin therapy market.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals, involved in creating treatments for a range of diseases, including those that could compete with skin-related therapies.
AMGEN
AMGN
Mkt Cap178B
Amgen Inc., a biotech firm that develops a wide range of treatments, including for skin conditions, making it a competitor.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical, focuses on enzyme replacement therapies, which could potentially overlap with SkinBioTherapeutics' market in treating skin conditions.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences, a biopharmaceutical company that, while focusing on antiviral drugs, also explores treatments that could compete in the skin health market.
Novartis
NVS
Mkt Cap279.67B
Novartis AG, a large pharmaceutical company with a diverse portfolio, including treatments for skin conditions, competing on a global scale.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca, engages in the discovery and development of pharmaceuticals for various diseases, including those affecting the skin, making it a competitor.

About

SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare and cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Show more...
CEO
Mr. Martin Braddock Hunt
Employees
41
Country
United Kingdom
ISIN
GB00BF33H870

Listings

STU
DE
5KW.STU
F
DE
5KW.F
LSE
GB
SBTX.LSE

0 Comments

Share your thoughts

FAQ

What is SkinBioTherapeutics stock price today?▼
The current price of SBTX.LSE is GBX0.1 GBX — it has increased by +0% in the past 24 hours. Watch SkinBioTherapeutics stock price performance more closely on the chart.
What is SkinBioTherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SkinBioTherapeutics stocks are traded under the ticker SBTX.LSE.
Is SkinBioTherapeutics stock price growing?▼
SBTX.LSE stock has risen by +0% compared to the previous week, the month change is a -99% fall, over the last year SkinBioTherapeutics has showed a -99.55% decrease.
What is SkinBioTherapeutics market cap?▼
Today SkinBioTherapeutics has the market capitalization of 252,309.51
When is the next SkinBioTherapeutics earnings date?▼
SkinBioTherapeutics is going to release the next earnings report on December 04, 2026.
What is SkinBioTherapeutics revenue for the last year?▼
SkinBioTherapeutics revenue for the last year amounts to 927.6M GBX.
What is SkinBioTherapeutics net income for the last year?▼
SBTX.LSE net income for the last year is -139.2M GBX.
How many employees does SkinBioTherapeutics have?▼
As of May 06, 2026, the company has 41 employees.
In which sector is SkinBioTherapeutics located?▼
SkinBioTherapeutics operates in the Essentials sector.
When did SkinBioTherapeutics complete a stock split?▼
SkinBioTherapeutics has not had any recent stock splits.
Where is SkinBioTherapeutics headquartered?▼
SkinBioTherapeutics is headquartered in Newcastle upon Tyne, United Kingdom.